Using tumour vaccination protocols with no interleukin-2 or α-interferon, Repmann et al (2003) and Jocham et al (2004) were the first investigators reporting positive adjuvant treatment results in locally advanced renal cell carcinoma. The gene discussed is IL2; the disease is renal cell carcinoma.